A major Australian medical company has suffered a $4.4b wipeout after slashing its earnings forecast, which drove its share ...
Cochlear’s shares have collapsed after the hearing implants behemoth again downgraded profit guidance by up to $170m on ...
Cochlear shares (ASX: COH) suffered their worst single-day decline since listing in 1995, crashing to a ten-year low after ...
The world’s gone cold on treating hearing loss and Australia’s Cochlear is bearing the brunt. Cochlear isn’t selling hearing ...
The hearing implant maker’s shares cratered to the lowest level since April 2016 amid the Middle East conflict and plunging ...
Monday - Friday, 10:00 - 11:00 SIN/HK | 0400 - 05:00 CET In this video Cochlear CEO Dig Howitt says its medical devices are largely exempt from tariffs. He also talks about the latest innovations and ...
Cochlear reduces its FY26 earnings guidance amid softer implant sales, ongoing challenges in key markets, and a focus on long ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results